MD SB430 | 2019 | Regular Session

Note: Carry Foward to future SB159

Status

Spectrum: Partisan Bill (Democrat 14-0)
Status: Introduced on February 1 2019 - 25% progression, died in chamber
Action: 2019-02-21 - Unfavorable Report by Finance; Withdrawn
Text: Latest bill text (Introduced) [PDF]

Summary

Requiring each authorized prescriber who receives a financial gratuity or incentive from a pharmaceutical distributor or manufacturer to file a certain disclosure form with the Maryland Health Care Commission within 30 days of the receipt of the financial gratuity or incentive: authorizing the Commission to impose a fine of up to $1,000 per violation; requiring the Commission to adopt certain regulations; and providing for the prospective application of the Act.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Maryland Health Care Commission - Authorized Prescribers - Reporting of Financial Gratuities or Incentives

Sponsors


History

DateChamberAction
2019-02-21SenateUnfavorable Report by Finance; Withdrawn
2019-02-18SenateHearing canceled
2019-02-05SenateHearing 2/20 at 1:00 p.m.
2019-02-01SenateFirst Reading Finance

Same As/Similar To

SB430 (Carry Over) 2019-02-21 - Unfavorable Report by Finance; Withdrawn

Subjects


Maryland State Sources


Bill Comments

feedback